STI Clinical Trials Dashboard

The STI Clinical Trials Dashboard provides information about trials focused on vaccines, diagnostics, and the use of doxycycline post-exposure prophylaxis (DoxyPEP) to detect, treat, and prevent chlamydia, gonorrhea, hepatitis B, herpes simplex virus (HSV), human papillomavirus, syphilis and trichomoniasis infections.

This information is primarily derived from the online database. While these studies may not produce a vaccine or diagnostic that can be implemented in community settings, this dashboard provides an overview of active trials working towards the goal of producing products to one day prevent, detect and treat STIs. This dashboard contains information about STI clinical trials by pathogen, country, key population, trial purpose, phase, start date and end date.

Of note, when displaying trials focused on STI vaccine development, both prophylactic and therapeutic vaccines were included in this category. Only trials listed as active as of June 2023, have been included in this dashboard and trials that include more than one pathogen have been classified as “multi-pathogen trials”.


Right clicking “Drill through” from selections in the dashboard will allow you to view details about the trials on the table in Page 2. Users can download this data as an Excel file to explore more of this information. Additionally, all graphics can be downloaded as a PowerPoint presentation. If you have any additional updates, corrections, or suggestions, please contact the AVAC STI program at

We recommend viewing the dashboard below in full screen mode. Click the double arrow on the lower right.


a. STI Clinical Trials Dashboard Data (Excel)
b. STI Clinical Trials Dashboard Graphics (PowerPoint)
c. STI Clinical Trials Dashboard Formatted Data Tables (PDF)